CRSP received an overall rating of 93, which means that it scores higher than 93% of stocks. Additionally, Crispr Therapeutics AG scored a 77 in the Healthcare sector, ranking it higher than 77% of stocks in that sector.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.
Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score.
The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Crispr Therapeutics AG Stock Today?
Crispr Therapeutics AG (CRSP) stock is higher by 2.48% while the S&P 500 is lower by -0.64% as of 10:26 AM on Tuesday, Jul 14. CRSP is higher by $2.14 from the previous closing price of $86.23 on volume of 280,432 shares. Over the past year the S&P 500 has gained 4.01% while CRSP is higher by 79.32%. CRSP earned $0.75 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 117.14.